Guido Filler
Filler, Guido 1959-
Filler, Guido
VIAF ID: 47593745 (Personal)
Permalink: http://viaf.org/viaf/47593745
Preferred Forms
-
- 100 1 _ ‡a Filler, Guido
- 100 1 _ ‡a Filler, Guido ‡d 1959-
- 100 1 _ ‡a Filler, Guido ‡d 1959-
- 100 0 _ ‡a Guido Filler
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Becoming a successful scholar, 2019: | |
Bedeutung Ia positiver [Eins-a-positiver] dendritischer Zellen für die Immunogenität eines Organtransplantats - tierexperimentelle Untersuchungen nach Transplantation von Herz und Pankreas von chimären Spendern bei der Ratte | |
Low agreement between modified-Schwartz and CKD-EPI eGFR in young adults: a retrospective longitudinal cohort study | |
Lower prevalence of aortic dilatation among preemptive pediatric renal transplant recipients - A cross-sectional cohort study | |
Macrohematuria with electron-dense deposits in a 14-year-old boy with minimal change nephrotic syndrome. | |
Marginal parent donors—Process and ethics | |
Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida | |
Measuring physicians' productivity: a three-year study to evaluate a new remuneration system | |
The merits of sequential transplantation for hyperoxaluria type I | |
Methods of assessing renal function. | |
Minimum mycophenolic acid levels are associated with donor-specific antibody formation. | |
Monitoring and improving renal outcomes after heart transplantation | |
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome | |
Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration | |
Native kidney BK virus nephropathy associated with acute lymphocytic leukemia | |
The need for ongoing monitoring of adherence to access targets | |
The need for tacrolimus assay standardization | |
Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders | |
Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations | |
Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma | |
Nighttime blood pressure, systolic blood pressure variability, and left ventricular mass index in children with hypertension | |
No association between cyclosporine levels and dyslipidemia? | |
Non-invasive measurement of cardiac output in obese children and adolescents: comparison of electrical cardiometry and transthoracic Doppler echocardiography. | |
Non-random distribution of mutations in the PHEX gene and under-detected missense mutations at non-conserved residues | |
Novel HGPRT 293 A>G point mutation presenting as neonatal acute renal failure | |
Online Calculator to Improve Counseling of Short-Term Neonatal Morbidity and Mortality Outcomes at Extremely Low Gestational Age (23-28 Weeks). | |
Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease | |
Pediatric nephrology patients are overweight: 20 years' experience in a single Canadian tertiary pediatric nephrology clinic | |
Pediatric reference intervals for immunoglobulin G and its subclasses with Siemens immunonephelometric assays | |
Pediatric reference intervals for soluble transferrin receptor and transferrin receptor-ferritin index | |
Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing | |
Pharmacokinetics of pyridostigmine in a child with postural tachycardia syndrome | |
Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants | |
Picture of the month: severe zinc deficiency in infancy (acrodermatitis enteropathica-like picture) | |
Plasma exchange using a continuous venovenous hemofiltration machine in children. | |
Practice recommendations for the monitoring of renal function in pediatric non-renal organ transplant recipients. | |
Preliminary reference intervals for cystatin C and beta-trace protein in preterm and term neonates | |
The problem with generic immunosuppressants | |
Progress in pediatric kidney transplantation. | |
Pseudomonas aeruginosa infection: an uncommon cause of post-renal obstruction following induction therapy for acute lymphoblastic leukemia | |
PTHrP-related Hypercalcaemia in Infancy and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). | |
Racial disparities in hemoglobin concentration in children with CKD | |
Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease | |
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. | |
Rapid resolution of tacrolimus intoxication-induced AKI with a corticosteroid and phenytoin. | |
Reference intervals for anion gap and strong ion difference in pregnancy: a pilot study | |
Relationships among serum iron, inflammation, and body mass index in children | |
Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab | |
Renal Length z-score for the Detection of Dysfunction in Children with Solitary Functioning Kidney | |
Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients. | |
Residual renal function calculated from serum cystatin C measurements and knowledge of the weekly standard Kt/V urea. | |
Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. | |
Reversible diabetes mellitus during growth hormone therapy in chronic renal failure | |
Rising part-time work in the academic pediatric workforce in Canada | |
Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab | |
The safety and use of short-acting nifedipine in hospitalized hypertensive children | |
The Search for More Reliable Estimated GFR Biomarkers | |
Shorter break-in period is a viable option with tighter PD catheter securing during the insertion | |
Should prevention of chronic kidney disease start before pregnancy? | |
Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? | |
Should we consider MMF therapy after rituximab for nephrotic syndrome? | |
Should we stop dosing steroids per body surface area for nephrotics? | |
Similar MPA exposure on modified release and regular tacrolimus | |
Sirolimus is not always responsible for new-onset proteinuria after conversion for chronic allograft nephropathy | |
Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome | |
Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis. | |
Spot urine protein to creatinine ratio. | |
Steroid-resistant acute allograft rejection in renal transplantation | |
Successful Treatment of Multiple Angiomyolipomas with Sirolimus in a Child | |
Tandem hemodialysis and plasma exchange. | |
Tissue HHV6 and 7 determination in pediatric solid organ recipients--a pilot study | |
Tissue viral DNA is associated with chronic allograft nephropathy. | |
To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription. | |
Trace elements in dialysis. | |
Transient diabetes mellitus and peripheral insulin resistance following Tacrolimus intoxication in a child after renal transplantation | |
Transient hyponatremia of prematurity caused by mild Bartter syndrome type II: a case report | |
Unexpectedly high exposure to enteric-coated mycophenolate sodium upon once-daily dosing. | |
Unexpectedly high inter- and intrapatient variability of ganciclovir levels in children | |
Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children | |
The urgent need for more research on how to treat recurrent focal and segmental glomerulosclerosis | |
The usefulness of cystatin C and related formulae in pediatrics. | |
Using individual DSA titers to assess for accommodation after late humoral rejection | |
V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms. | |
What is single needle cannulation hemodialysis: is it adequate? | |
What is the intrapatient variability of mycophenolic acid trough levels? | |
Why multidisciplinary clinics should be the standard for treating chronic kidney disease | |
β-trace protein may be a more suitable marker of neonatal renal function. |